Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

Launches Evome Medical Products Distribution Company, Appoints Bill Garbarini Chief Operating Officer Adding Plan for a broader portfolio of Life Science Products SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) — Shirley, New York, November 25, 2